Closing the Gap in Care in Seronegative Inflammatory Arthritis (Metrix II)
This study is currently recruiting participants.
Verified May 2013 by Pope Research Corporation
Sponsor:
Pope Research Corporation
Collaborators:
AMOSO
CIORA
Abbott
Information provided by (Responsible Party):
Pope Research Corporation
ClinicalTrials.gov Identifier:
NCT01749618
First received: November 6, 2012
Last updated: May 21, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.
| Condition | Intervention |
|---|---|
|
SpA PsA |
Behavioral: Education and Feedback |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change |
Further study details as provided by Pope Research Corporation:
Primary Outcome Measures:
- Improvement of Systematic Assessments [ Time Frame: November 2012 - November 2013 ] [ Designated as safety issue: No ]Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded.
| Estimated Enrollment: | 40 |
| Study Start Date: | November 2012 |
| Estimated Study Completion Date: | November 2013 |
| Estimated Primary Completion Date: | November 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: No education or feedback
Rheumatologists randomized to this treatment arm receive no additional education or feedback about their systematic assessments of patients
|
|
|
Experimental: Education and Feedback
Rheumatologists randomized to receive education and feedback participate in six web conferences designed to improve their systematic assessments of their patients, and are given feedback about their performances
|
Behavioral: Education and Feedback
Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Canadian Rheumatologist
Exclusion Criteria:
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01749618
Contacts
| Contact: Paul C Tingey, BSc, BEd | 519-709-8452 | prcpaultingey@gmail.com |
Locations
| Canada, Ontario | |
| Dr. Vandana Ahluwalia | Recruiting |
| Brampton, Ontario, Canada | |
| Principal Investigator: Vandana Ahluwalia, MD | |
| Dr. Sanjay Dixit | Recruiting |
| Burlington, Ontario, Canada, L7L 0B7 | |
| Principal Investigator: Sanjay Dixit, MD | |
| Dr Pauline Boulos | Recruiting |
| Hamilton, Ontario, Canada, L8N 1Y2 | |
| Principal Investigator: Pauline Boulos, MD | |
| Dr. Nikhil Chopra | Recruiting |
| London, Ontario, Canada, N6B 2E8 | |
| Principal Investigator: Nikhil Chopra, MD | |
| Credit Valley Rheumatology | Recruiting |
| Mississauga, Ontario, Canada, L5M 2V8 | |
| Principal Investigator: Andrew Chow, MD | |
| Dr Angela Montgomery | Recruiting |
| Mississauga, Ontario, Canada, L5B 2P7 | |
| Principal Investigator: Angela Montgomery, MD | |
| The Medical Centre | Not yet recruiting |
| Peterborough, Ontario, Canada, K9J 7B3 | |
| Principal Investigator: Jane Purvis, MD | |
| Dr. Arthur Karasik | Recruiting |
| Toronto, Ontario, Canada, M9C 5N2 | |
| Principal Investigator: Arthur Karasik, MD | |
| Sunnybrook Health Sciences Centre | Recruiting |
| Toronto, Ontario, Canada, M4N 3M5 | |
| Principal Investigator: Emily McKeown, MD | |
Sponsors and Collaborators
Pope Research Corporation
AMOSO
CIORA
Abbott
Investigators
| Principal Investigator: | Janet E Pope, MD, MPH, FRCPC | Pope Research Corp., St. Joseph's Health Care, Western University |
More Information
No publications provided
| Responsible Party: | Pope Research Corporation |
| ClinicalTrials.gov Identifier: | NCT01749618 History of Changes |
| Other Study ID Numbers: | Metrix II |
| Study First Received: | November 6, 2012 |
| Last Updated: | May 21, 2013 |
| Health Authority: | Canada: Health Canada |
Keywords provided by Pope Research Corporation:
|
Seronegative Inflammatory Arthritis SpA PsA Randomized Behavioural Change |
Additional relevant MeSH terms:
|
Arthritis Joint Diseases Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on May 23, 2013